Figure 1.

Short Form 36 (SF-36) at baseline and after 24 weeks of treatment with mycophenolate sodium in patients with primary Sjögren syndrome (n = 8). The SF-36 domains are physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), mental health (MH), and the physical and mental component summary scores (PCS and MCS). The GH and RE domains increased significantly (p < 0.05) after 24 weeks (*). The increase of the MCS did not reach significance (**p = 0.06).